Apimeds engages IBN to expand investor communications across 5,000+ outlets

Verifying
  • Apimeds Pharmaceuticals US engages IBN for corporate communications support.
  • 5,000+ syndication outlets are included in IBN’s investor-focused distribution network.
  • MindWave Innovations is developing four ecosystems under its MindChain platform.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.